[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Kymera Therapeutics, a clinical-stage biotech company, is working to transform the treatment of immuno-inflammatory diseases through oral medicines. Analysts are discussing the company's approach, comparing it to injections from competitors, and noting that efficacy and freedom from daily dosing may be more important to patients than the convenience of an oral pill. The company is among several biotech firms expected to have significant clinical trial results and catalysts in the near future.
Kymera Therapeutics, Inc. Common Stock uses the ticker $KYMR for trading. Listed in the Stocks and category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
24-Hour | 7-Day | 30-Day |
---|---|---|
-XXXX% | -XXX% | XXXXX% |
1-Year High: $XXXXX on 2025-10-13
1-Year Low: $XXXXX on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Kymera Therapeutics, Inc. Common Stock (KYMR) is currently AltRank #198 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXX -XX
6 Months: XXX -XXX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-08-06
1-Year Low: XX on 2025-01-11
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +10
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-01-14
1-Year Low: X on 2025-08-06
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX +1.40%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +101%
1 Year: XXXXXXXXX +87%
1-Year High: XXXXXXX on 2025-06-02
1-Year Low: XXX on 2025-02-03
Social Network | X |
---|---|
Engagements | XXXXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX +190%
1 Year: XXXXX +383%
1-Year High: XXXXX on 2025-07-06
1-Year Low: XX on 2025-01-28
Social Network | X |
---|---|
Mentions | XX |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Kymera Therapeutics, Inc. Common Stock (KYMR) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +318%
1 Year: XXXXX +311%
1-Year High: XXX on 2025-07-06
1-Year Low: X on 2025-01-28
The most influential creators that mention Kymera Therapeutics, Inc. Common Stock in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@HOThomasWPhelps | X | XXX | XX | XXXXX |
@semodough | X | XXXXXX | X | XXXXX |
@MacroSkokie | X | XXXXX | X | XXX |
@Andre_AGTC | X | XXXXX | X | XXX |
@linhnguyen64143 | X | XX | X | XX |
@SteveDJacobs | X | XXXXX | X | XX |
@Biobeats99 | X | XXX | X | XX |
@MarcJacksonLA | X | XXXXX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2025-01-30
1-Year Low: XX% on 2025-04-13
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% +0.00696%
1 Month: XXXXX% +0.012%
6 Months: XXXXX% +0.008%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-07-06
1-Year Low: XXXXXX% on 2025-09-14
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-04-08
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$2.40%
1 Month: $XXXXXXXXXXXXX +$24%
6 Months: $XXXXXXXXXXXXX +$147%
1 Year: $XXXXXXXXXXXXX +$40%
1-Year High: $XXXXXXXXXXXXX on 2025-10-13
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Kymera Therapeutics, Inc. Common Stock in the last XX hours
Sanofi (SNY) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Regeneron Pharmaceuticals Inc (REGN) Corcept Therapeutics Inc. (CORT) Apogee Therapeutics, Inc. Common Stock (APGE) Revolution Medicines, Inc. Common Stock (RVMD) Merus N.V. Common Shares (MRUS) Incyte Corporation (INCY) Summit Therapeutics Inc. Common Stock (SMMT)
Top topics mentioned In the posts about Kymera Therapeutics, Inc. Common Stock in the last XX hours
stocks healthcare, stocks consumer cyclical, sanofi, investment, $rytm, coins defi, regeneron pharmaceuticals inc, coins solana ecosystem, $cort, stocks bitcoin treasuries, $apge, stocks, $crvs, telegram, stocks technology, $rvmd, stocks energy, $barcl, $mrus, $incy, $smmt, tesla, $prgo, coins dao, stocks bitcoin miners, $crsp, $dnli, $elan, $psnl, $sam, $xene, $beam, $axsm, $auph, $onc, $acad, $mdgl, stocks basic materials, coins bsc, $akro, $pcvx, $ptct, $abbv, $regn, $sny, $14b, alnylam pharmaceuticals inc, $alny, $bbio, $insm, $vrna, compound, $20m, $975m, united states, $bntx, $sbsw, $kt, $bwxt, $cuk, monaco, breaking news, the only, $zyme, $blue, stocks crypto treasuries, $amgn, eli lilly, $roiv, $rgc, $pfe, $mtsr, $xbi, $cgon, $mlys, $1b, $alhc, $cccc, $rna, $nuvl, $sxi, $tbbk, coins base ecosystem, $ewtx, $aaoi, $adpt, $agx, $arlo, $ag, $air, $alm, $ampx, $apld, $ego, $emx, stocks utilities, $fold, coins depin, $geni, $olma
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$KYMR $XXXXX Kymera protein degradation pipeline gaps eyes on lows. 🔥 🎉"
X Link @karnkarn249 2025-10-14T23:46Z XX followers, X engagements
"Either via calls or common or both I am long the following - $ALNY $KYMR $INDV $BBIO $ABVX and $RYTM"
X Link @MacroSkokie 2025-10-14T16:10Z 1363 followers, XXX engagements
"Biotech remains a standout. Check out $BBIO $ALNY $ABVX and $KYMR among others"
X Link @MacroSkokie 2025-10-13T19:04Z 1363 followers, 1473 engagements
"$CRVS Barclays OW PT$16 view of a positive risk-reward for Corvus' ITK inhibitor soquelitinib (CPI-818) ahead of atopic dermatitis (AD) data this quarter as believe soqueltinib has a differentiated mechanism of action with early clinical data that suggests clinical benefit in AD. Upside case USD XXXXX Our upside scenario reflects data in atopic dermaitis above our expectations"
X Link @semodough 2025-10-13T14:28Z 41.4K followers, 19.9K engagements